Look for:

PHARMING GROUP N.V.


ISIN:
NL0010391025
WKN:
518940

2024/03/28 08:59:59
Price
1.0128 EUR
Difference 1.63% (0.02)

General attributes

ISINNL0010391025
SymbolPHARM
ExchangeLondon Stock Exchange European Trade Reporting
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)687 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)0.9945 EUR (75,000)
Ask (Ask size)1.045 EUR (75,000)
Open1.0128 EUR
High1.0128 EUR
Low1.0128 EUR
Close (prev. day)0.9965 EUR
VWAP1.10 EUR
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 08:59:59
Price
1.0128 EUR
Difference 1.63% (0.02)

General attributes

ISINNL0010391025
SymbolPHARM
ExchangeLondon Stock Exchange European Trade Reporting
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)687 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)0.9945 EUR (75,000)
Ask (Ask size)1.045 EUR (75,000)
Open1.0128 EUR
High1.0128 EUR
Low1.0128 EUR
Close (prev. day)0.9965 EUR
VWAP1.10 EUR
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Performance and Risk

6m1y3y
Perf (%)-18.05%-12.93%-8.77%
Perf (abs.)-0.22-0.15-0.10
Beta0.930.780.76
Volatility33.0536.6440.61
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.0278 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)1.0386 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)1.0774 EUR (22,771)
Ø price 250 days | Ø volume 250 days (pcs.)1.0998 EUR (24,620)
YTD High | date1.2000 EUR (2024/01/10)
YTD Low | date0.9965 EUR (2024/03/27)
52 Weeks High | date1.2990 EUR (2023/09/18)
52 Weeks Low | date0.9728 EUR (2023/04/19)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/03/2811:571.015 EUR0.004
Stuttgart2024/03/2814:201.02 EUR0.004
Munich2024/03/2808:161.014 EUR0.001
London Stock Exchange European Trade Reporting2024/03/2808:591.0128 EUR0.001
Frankfurt2024/03/2808:090.999 EUR0.001
FINRA other OTC Issues2024/03/1118:491.20 USD0.004
Euronext Amsterdam2024/03/2814:261.023 EUR3.26628
Duesseldorf2024/03/2808:101.005 EUR0.001
Berlin2024/03/2808:161.008 EUR0.001
BX Swiss2023/04/1118:001.118 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=14223&ID_TYPE_IMAGE_LOGO=2

Contact Details

PHARMING GROUP NV
- -
Darwinweg 24 - 2332 CR Leiden
Telefon: +31-71-524-74-00
Fax: +31-71-524-74-45
E-mail: info@pharming.com

Company Profile

-

Board of directors

Richard PetersChairman of Supervisory Board
Jabine T. M. van der MeijsMember of Supervisory Board
Mark PykettMember of Supervisory Board
Barbara YanniMember of Supervisory Board
Deborah JornMember of Supervisory Board
Leonard KruimerMember of Supervisory Board
Steven BaertMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.